BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(42): 5286-5296 [PMID: 21072891 DOI: 10.3748/wjg.v16.i42.5286]
URL: https://www.wjgnet.com/1007-9327/full/v16/i42/5286.htm
Number Citing Articles
1
Karen Smayra, Shahid Miangul, Nathanael Yap, Ao Shi, Fatma Abdulsalam, Maamoun Adra, Hayato Nakanishi, Jake Ball, Tara A. Betts, Christian A. Than, Aneeta Parthipun. Technical Success, Sample Adequacy, and Complications of  Pediatric Transjugular Liver Biopsy: A Systematic Review and Meta-AnalysisDigestive Diseases and Sciences 2023; 68(10): 3846 doi: 10.1007/s10620-023-08071-4
2
Shinhiti Morita, Dalísio De Santi Neto, Flávio Hiroshi Ananias Morita, Nina Kimie Morita, Suzana Margareth Ajeje Lobo. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric SurgeryObesity Surgery 2015; 25(12): 2335 doi: 10.1007/s11695-015-1696-5
3
Shadae R. Foster, Lowell L. Dilworth, Rory K. Thompson, Ruby L. Alexander-Lindo, Felix O. Omoruyi. Effects of combined inositol hexakisphosphate and inositol supplement on antioxidant activity and metabolic enzymes in the liver of streptozotocin-induced type 2 diabetic ratsChemico-Biological Interactions 2017; 275: 108 doi: 10.1016/j.cbi.2017.07.024
4
Berend J. van Welzen, Tania Mudrikova, Ayman El Idrissi, Andy I. M. Hoepelman, Joop E. Arends. A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?Infectious Diseases and Therapy 2019; 8(1): 33 doi: 10.1007/s40121-018-0229-7
5
Miren García-Cortés, Juan Pedro Toro-Ortiz, Alberto García-García. Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative reviewExploration of Digestive Diseases 2023; : 318 doi: 10.37349/edd.2023.00034
6
Gerald Y. Minuk, Venera Iliant, Nancy Zhou, Kelly D. Kaita, Stephen G. Wong, David Peretz, Julia Uhanova. Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitisLiver International 2018; 38(6): 1110 doi: 10.1111/liv.13644
7
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of DiabetesClinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
8
Neti Jayanti, Rozzana Said, Suhaidah Jofrry, Chee-Yan Choo. Mechanistic pathway of herbs in the amelioration of NAFLD: A systematic reviewWorld Academy of Sciences Journal 2024; 6(4) doi: 10.3892/wasj.2024.245
9
Yang Zhang, Gerd Bobe, Cristobal L Miranda, Malcolm B Lowry, Victor L Hsu, Christiane V Lohr, Carmen P Wong, Donald B Jump, Matthew M Robinson, Thomas J Sharpton, Claudia S Maier, Jan F Stevens, Adrian F Gombart. Tetrahydroxanthohumol, a xanthohumol derivative, attenuates high-fat diet-induced hepatic steatosis by antagonizing PPARγeLife 2021; 10 doi: 10.7554/eLife.66398
10
James C. Barton, J. Clayborn Barton, Ronald T. Acton. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282YBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02763-x
11
Yusuf Yilmaz, Zobair M. Younossi. Obesity-Associated Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2014; 18(1): 19 doi: 10.1016/j.cld.2013.09.018
12
M. Bekaert, X. Verhelst, A. Geerts, B. Lapauw, P. Calders. Association of recently described adipokines with liver histology in biopsy‐proven non‐alcoholic fatty liver disease: a systematic reviewObesity Reviews 2016; 17(1): 68 doi: 10.1111/obr.12333
13
Fan-Jhen Dai, Wei-Hsuan Hsu, Jan-Jeng Huang, She-Ching Wu. Effect of pigeon pea (Cajanus cajan L.) on high-fat diet-induced hypercholesterolemia in hamstersFood and Chemical Toxicology 2013; 53: 384 doi: 10.1016/j.fct.2012.12.029
14
Marco Arrese, Juan Pablo Arab, Juan Pablo Arancibia, Roberto Candia, Arnoldo Riquelme, Francisco Barrera. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome2012; : 289 doi: 10.1016/B978-0-12-385083-6.00023-1
15
Linjie Qiu, Bin Kong, Tiantian Kong, Huan Wang. Recent advances in liver‐on‐chips: Design, fabrication, and applicationsSmart Medicine 2023; 2(1) doi: 10.1002/SMMD.20220010
16
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Erin Rubin, Parmjeet Randhawa, Eizaburo Sasatomi. Textbook of Organ Transplantation2014; : 927 doi: 10.1002/9781118873434.ch82
17
Jain Kumar, Jeffery Teckman. Controversies in the Mechanism of Total Parenteral Nutrition Induced PathologyChildren 2015; 2(3): 358 doi: 10.3390/children2030358
18
Chun‐Seok Cho, Hwan‐Woo Park, Allison Ho, Ian A. Semple, Boyoung Kim, Insook Jang, Haeli Park, Shannon Reilly, Alan R. Saltiel, Jun Hee Lee. Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1–mediated p62/sequestosome 1 phosphorylationHepatology 2018; 68(4): 1331 doi: 10.1002/hep.29742
19
Xavier Loyer, Valérie Paradis, Carole Hénique, Anne-Clémence Vion, Nathalie Colnot, Coralie L Guerin, Cécile Devue, Sissi On, Jérémy Scetbun, Mélissa Romain, Jean-Louis Paul, Marc E Rothenberg, Patrick Marcellin, François Durand, Pierre Bedossa, Carina Prip-Buus, Eric Baugé, Bart Staels, Chantal M Boulanger, Alain Tedgui, Pierre-Emmanuel Rautou. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expressionGut 2016; 65(11): 1882 doi: 10.1136/gutjnl-2014-308883
20
Yuji Oe, Mieko Ko, Tomofumi Fushima, Emiko Sato, S. Ananth Karumanchi, Hiroshi Sato, Junichi Sugawara, Sadayoshi Ito, Nobuyuki Takahashi. Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthaseScientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18260-7
21
Anna Alisi, Ariel E. Feldstein, Alberto Villani, Massimiliano Raponi, Valerio Nobili. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approachNature Reviews Gastroenterology & Hepatology 2012; 9(3): 152 doi: 10.1038/nrgastro.2011.273
22
Yusuf Yilmaz, Yasar Colak, Ramazan Kurt, Ebubekir Senates, Fatih Eren. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and BackTumori Journal 2013; 99(1): 10 doi: 10.1177/030089161309900102
23
Munechika Enjoji, Kenichiro Yasutake, Motoyuki Kohjima, Makoto Nakamuta. Alcohol, Nutrition, and Health Consequences2013; : 523 doi: 10.1007/978-1-62703-047-2_40
24
Mara Lúcia de Campos, Marina Bento de Castro, Artur Domingos Campos, Maria Fernanda Fernandes, Jéssica Leiras Mota Conegundes, Matheus Nehrer Rodrigues, Fernanda Lins Brandão Mügge, Aristóbolo Mendes da Silva, Céphora Maria Sabarense, Maria Christina Marques Nogueira Castañon, Ana Eliza Andreazzi, Elita Scio. Antiobesity, hepatoprotective and anti-hyperglycemic effects of a pharmaceutical formulation containing Cecropia pachystachya Trécul in mice fed with a hypercaloric dietJournal of Ethnopharmacology 2021; 280: 114418 doi: 10.1016/j.jep.2021.114418
25
Roderich E. Schwarz, Jordan D. Berlin, Heinz J. Lenz, Bernard Nordlinger, Laura Rubbia‐Brandt, Michael A. Choti. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statementHPB 2013; 15(2): 106 doi: 10.1111/j.1477-2574.2012.00558.x
26
Aman Sharma. Lipid droplets associated perilipins protein insights into finding a therapeutic target approach to cure non-alcoholic fatty liver disease (NAFLD)Future Journal of Pharmaceutical Sciences 2022; 8(1) doi: 10.1186/s43094-021-00395-0
27
Hamed Zamanian, Ahmad Shalbaf. Grading of steatosis, fibrosis, lobular inflammation, and ballooning from liver pathology images using pre‐trained convolutional neural networksInternational Journal of Imaging Systems and Technology 2023; 33(6): 2178 doi: 10.1002/ima.22936
28
Sandrine Barbois, Catherine Arvieux, Vincent Leroy, Fabian Reche, Nathalie Stürm, Anne-Laure Borel. Benefit–risk of intraoperative liver biopsy during bariatric surgery: review and perspectivesSurgery for Obesity and Related Diseases 2017; 13(10): 1780 doi: 10.1016/j.soard.2017.07.032
29
Mariana Catta-Preta, Leonardo Souza Mendonca, Julio Fraulob-Aquino, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda. A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsiesVirchows Archiv 2011; 459(5): 477 doi: 10.1007/s00428-011-1147-1
30
Dinali H. Fernando, Josephine M. Forbes, Peter W. Angus, Chandana B. Herath. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End ProductsInternational Journal of Molecular Sciences 2019; 20(20): 5037 doi: 10.3390/ijms20205037
31
Brett McGettigan, Rachel McMahan, David Orlicky, Matthew Burchill, Thomas Danhorn, Prashanth Francis, Lin Ling Cheng, Lucy Golden‐Mason, Claudia V. Jakubzick, Hugo R. Rosen. Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating MacrophagesHepatology 2019; 70(1): 67 doi: 10.1002/hep.30401
32
Marjolein H. Tiebosch, Golnar Karimian, Han Moshage. Studies on Hepatic DisordersOxidative Stress in Applied Basic Research and Clinical Practice 2015; : 99 doi: 10.1007/978-3-319-15539-5_4
33
Vatche G. Agopian, Fady M. Kaldas, Johnny C. Hong, Meredith Whittaker, Curtis Holt, Abbas Rana, Ali Zarrinpar, Henrik Petrowsky, Douglas Farmer, Hasan Yersiz, Victor Xia, Jonathan R. Hiatt, Ronald W. Busuttil. Liver Transplantation for Nonalcoholic SteatohepatitisAnnals of Surgery 2012; 256(4): 624 doi: 10.1097/SLA.0b013e31826b4b7e
34
Maria Teresa Borrello, Maria Rita Emma, Angela Listi, Marion Rubis, Sergiu Coslet, Giuseppa Augello, Antonella Cusimano, Daniela Cabibi, Rossana Porcasi, Lydia Giannitrapani, Maurizio Soresi, Gianni Pantuso, Karen Blyth, Giuseppe Montalto, Christopher Pin, Melchiorre Cervello, Juan Iovanna. NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress responseThe FASEB Journal 2021; 35(3) doi: 10.1096/fj.202002413RR
35
Azam Asilian Bidgoli, Shahryar Rahnamayan, Taher Dehkharghanian, Abtin Riasatian, Hamid R. Tizhoosh. Evolutionary Computation in Action: Hyperdimensional Deep Embedding Spaces of Gigapixel Pathology ImagesIEEE Transactions on Evolutionary Computation 2023; 27(1): 52 doi: 10.1109/TEVC.2022.3178299
36
Ajay Kumar Jain, Abhineet Sharma, Sumit Arora, Keith Blomenkamp, Ik Chan Jun, Robert Luong, David John Westrich, Aayush Mittal, Paula M. Buchanan, Miguel A. Guzman, John Long, Brent A. Neuschwander‐Tetri, Jeffery Teckman. Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid–Treated Animals Receiving Parenteral NutritionJournal of Parenteral and Enteral Nutrition 2017; 41(2): 198 doi: 10.1177/0148607116661838
37
Ajay Kumar Jain, Carel W. le Roux, Puneet Puri, Ali Tavakkoli, Nana Gletsu‐Miller, Blandine Laferrère, Richard Kellermayer, John K. DiBaise, Robert G. Martindale, Bruce M. Wolfe. Proceedings of the 2017 ASPEN Research Workshop—Gastric Bypass: Role of the GutJournal of Parenteral and Enteral Nutrition 2018; 42(2): 279 doi: 10.1002/jpen.1121
38
Lindsei K. Sarna, Yaw L. Siow, Karmin O. The CBS/CSE system: a potential therapeutic target in NAFLD?Canadian Journal of Physiology and Pharmacology 2015; 93(1): 1 doi: 10.1139/cjpp-2014-0394
39
Vahide Betül CANITEZ, İbrahim GÜNEY, Edip ERKUŞ. Metabolik Sendromlu Olmayan Hastalarda Non-Alkolik Yağlı Karaciğer HastalığıBatı Karadeniz Tıp Dergisi 2021; 5(2): 143 doi: 10.29058/mjwbs.811398
40
J. A. Kramer, J. Grindley, A. M. Crowell, L. Makaron, R. Kohli, M. Kirby, K. G. Mansfield, L. M. Wachtman. The Common Marmoset as a Model for the Study of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisVeterinary Pathology 2015; 52(2): 404 doi: 10.1177/0300985814537839
41
Michele d’Angelo, Vanessa Castelli, Maria Grazia Tupone, Mariano Catanesi, Andrea Antonosante, Reyes Dominguez-Benot, Rodolfo Ippoliti, Anna Maria Cimini, Elisabetta Benedetti. Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARsInternational Journal of Molecular Sciences 2019; 20(21): 5422 doi: 10.3390/ijms20215422
42
Fabio Piscaglia, Bernardo Stefanini, Eleonora Terzi, Mariarosaria Marseglia, Vito Cantisani. Liver Fat Quantification: When do We Need It?Ultraschall in der Medizin - European Journal of Ultrasound 2023; 44(02): 120 doi: 10.1055/a-2015-5693
43
Mari Lahelma, Sami Qadri, Noora Ahlholm, Kimmo Porthan, Maija Ruuth, Anne Juuti, Matej Orešič, Tuulia Hyötyläinen, Katariina Öörni, Hannele Yki-Järvinen. The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particlesAtherosclerosis 2022; 363: 22 doi: 10.1016/j.atherosclerosis.2022.11.018
44
Helena S. Leitão, Sabrina Doblas, Gaspard d’Assignies, Philippe Garteiser, Jean-Luc Daire, Valérie Paradis, Carlos F. G. C. Geraldes, Valérie Vilgrain, Bernard E. Van Beers. Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosisEuropean Radiology 2013; 23(2): 461 doi: 10.1007/s00330-012-2626-8
45
Pathik Parikh, Jatin Patel, Meghraj Ingle, Prabha Sawant. Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in IndiaIndian Journal of Gastroenterology 2015; 34(3): 200 doi: 10.1007/s12664-015-0572-5
46
Claire Mancia, Véronique Loustaud-Ratti, Paul Carrier, Florian Naudet, Eric Bellissant, François Labrousse, Nicolas Pichon. Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead DonorsTransplantation 2015; 99(8): 1619 doi: 10.1097/TP.0000000000000652
47
Ana C. TUYAMA, Charissa Y. CHANG. Non‐alcoholic fatty liver diseaseJournal of Diabetes 2012; 4(3): 266 doi: 10.1111/j.1753-0407.2012.00204.x
48
Hidekatsu KURODA, Tamami ABE, Yudai FUJIWARA, Tomoaki NAGASAWA, Yasuhiro TAKIKAWA. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver diseaseChoonpa Igaku 2023; 50(3): 161 doi: 10.3179/jjmu.JJMU.R.219
49
Margeyi Mehta, Jigish Shah, Urvish Joshi. Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South AsiansCureus 2024;  doi: 10.7759/cureus.70768
50
Enrico Magosso, Mukhtar Alam Ansari, Yogheswaran Gopalan, Ibrahim Lutfi Shuaib, Jia-Woei Wong, Nurzalina Abdul Karim Khan, Mohamed Rizal Abu Bakar, Bee-Hong Ng, Kah-Hay Yuen. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trialNutrition Journal 2013; 12(1) doi: 10.1186/1475-2891-12-166
51
Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day. Non‐Alcoholic Fatty Liver Disease2013; : 1 doi: 10.1002/9781118556153.ch1
52
Elizabeth M. Brunt, David E. Kleiner, Danielle H. Carpenter, Mary Rinella, Stephen A. Harrison, Rohit Loomba, Zobair Younossi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal. NAFLD: Reporting Histologic Findings in Clinical PracticeHepatology 2021; 73(5): 2028 doi: 10.1002/hep.31599
53
Myriam Moretto, Carlos Kupski, Vinicius Duval da Silva, Alexandre V. Padoin, Cláudio C. Mottin. Effect of Bariatric Surgery on Liver FibrosisObesity Surgery 2012; 22(7): 1044 doi: 10.1007/s11695-011-0559-y
54
Daniella Braz Parente. Imaging methods in the assessment of nonalcoholic fatty liver diseaseRadiologia Brasileira 2020; 53(2): IX doi: 10.1590/0100-3984.2020.53.2e3
55
Yasuyuki Shigematsu, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Kentaro Inamura. Relationships between tumor CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinomaVirchows Archiv 2024;  doi: 10.1007/s00428-024-03939-w
56
Yunqiu Xia, Qing Li, Weizhen Zhong, Jing Dong, Zhulin Wang, Chunbo Wang. L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial functionDiabetology & Metabolic Syndrome 2011; 3(1) doi: 10.1186/1758-5996-3-31
57
Everton Cazzo, José Carlos Pareja, Elinton Adami Chaim. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive reviewSao Paulo Medical Journal 2017; 135(3): 277 doi: 10.1590/1516-3180.2016.0306311216
58
Anna Alisi, Guido Carpino, Valerio Nobili. Paediatric nonalcoholic fatty liver diseaseCurrent Opinion in Gastroenterology 2013; 29(3): 279 doi: 10.1097/MOG.0b013e32835ff95e
59
Dario F. De Jesus, Tomohiko Kimura, Manoj K. Gupta, Rohit N. Kulkarni. NREP contributes to development of NAFLD by regulating one-carbon metabolism in primary human hepatocytesCell Chemical Biology 2023; 30(9): 1144 doi: 10.1016/j.chembiol.2023.06.001
60
Pierre-Marie Lavrut, Olivier Guillaud, Jérôme Dumortier, Elisabeth Mintz, Virginie Brun, Sophie Heissat, Eduardo Couchonnal Bedoya, Alain Lachaux, Muriel Bost, Valerie Hervieu. Histological features of liver disease development in the Atp7b−/−mouse: a model of Wilson’s diseaseJournal of Clinical Pathology 2023; : jcp-2023-209190 doi: 10.1136/jcp-2023-209190
61
Dina G. Tiniakos, Quentin M. Anstee, Alastair D. Burt. Macsween's Pathology of the Liver2018; : 308 doi: 10.1016/B978-0-7020-6697-9.00005-4
62
Daniella Braz Parente, Jaime Araújo Oliveira Neto, Pedro Emmanuel Alvarenga Americano Brasil, Fernando Fernandes Paiva, José Pedro Rodrigues Ravani, Marilia Brito Gomes, Valeria Lanzoni, Carlos Frederico Ferreira Campos, Lilian Machado‐Silva, Renata Mello Perez, Rosana Souza Rodrigues. Preperitoneal fat as a non‐invasive marker of increased risk of severe non‐alcoholic fatty liver disease in patients with type 2 diabetesJournal of Gastroenterology and Hepatology 2018; 33(2): 511 doi: 10.1111/jgh.13903
63
Marcus Alvarez, Jihane N. Benhammou, Nicholas Darci-Maher, Samuel W. French, Steven B. Han, Janet S. Sinsheimer, Vatche G. Agopian, Joseph R. Pisegna, Päivi Pajukanta. Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survivalGenome Medicine 2022; 14(1) doi: 10.1186/s13073-022-01055-5
64
Akiko Suzuki, Keisuke Kakisaka, Yuji Suzuki, Ting Wang, Yasuhiro Takikawa. c-Jun N-terminal kinase-mediated Rubicon expression enhances hepatocyte lipoapoptosis and promotes hepatocyte ballooningWorld Journal of Gastroenterology 2016; 22(28): 6509-6519 doi: 10.3748/wjg.v22.i28.6509
65
Violaine Capitan, Jean-Michel Petit, Serge Aho, Pierre-Henri Lefevre, Sylvain Favelier, Romaric Loffroy, Patrick Hillon, Denis Krausé, Jean-Pierre Cercueil, Boris Guiu. Macroscopic heterogeneity of liver fat: an MR-based study in type-2 diabetic patientsEuropean Radiology 2012; 22(10): 2161 doi: 10.1007/s00330-012-2468-4
66
Gashaw Hassen, Abhishek Singh, Gizeshwork Belete, Nidhi Jain, Ivonne De la Hoz, Genesis P Camacho-Leon, Nitsuh K Dargie, Keila G Carrera, Tadesse Alemu, Sharan Jhaveri, Nebiyou Solomon. Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular DiseaseCureus 2022;  doi: 10.7759/cureus.25495
67
Daniel Andrade Tinoco de Souza, Daniella Braz Parente, Antonio Luis Eiras de Araújo, Koenraad J. Mortelé. Modern Imaging Evaluation of the LiverMagnetic Resonance Imaging Clinics of North America 2013; 21(2): 337 doi: 10.1016/j.mric.2013.01.001
68
Stepan Melnyk, Soheila Korourian, Joseph Levy, Oleksandra Pavliv, Teresa Evans, Reza Hakkak. Effects of Obesity on Pro-Oxidative Conditions and DNA Damage in Liver of DMBA-Induced Mammary Carcinogenesis ModelsMetabolites 2017; 7(2): 26 doi: 10.3390/metabo7020026
69
Michael Taulo Lund, Marianne Kristensen, Merethe Hansen, Louise Tveskov, Andrea Karen Floyd, Mikael Støckel, Ben Vainer, Steen Seier Poulsen, Jørn Wulff Helge, Clara Prats, Flemming Dela. Hepatic mitochondrial oxidative phosphorylation is normal in obese patients with and without type 2 diabetesThe Journal of Physiology 2016; 594(15): 4351 doi: 10.1113/JP272105
70
Evgin Goceri, Zarine K. Shah, Rick Layman, Xia Jiang, Metin N. Gurcan. Quantification of liver fat: A comprehensive reviewComputers in Biology and Medicine 2016; 71: 174 doi: 10.1016/j.compbiomed.2016.02.013
71
Mohamed Bejaoui, Mohamed Amine Zaouali, Emma Folch-Puy, Eirini Pantazi, Fawzia Bardag-Gorce, Teresa Carbonell, Joan Oliva, Antoni Rimola, Hassen Ben Abdennebi, Joan Roselló-Catafau. Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathwaysJournal of Pharmacy and Pharmacology 2014; 66(1): 62 doi: 10.1111/jphp.12154
72
Julien Rogier, Stéphanie Roullet, François Cornélis, Matthieu Biais, Alice Quinart, Philippe Revel, Paulette Bioulac‐Sage, Brigitte Le Bail. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver‐to‐spleen attenuation ratioLiver Transplantation 2015; 21(5): 690 doi: 10.1002/lt.24105
73
Elina Petäjä, Hannele Yki-Järvinen. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic ReviewInternational Journal of Molecular Sciences 2016; 17(5): 633 doi: 10.3390/ijms17050633
74
R Christopher Harmon, Dina G Tiniakos, Curtis K Argo. Inflammation in nonalcoholic steatohepatitisExpert Review of Gastroenterology & Hepatology 2011; 5(2): 189 doi: 10.1586/egh.11.21
75
Manuela G. Neuman, Samuel W. French, Samir Zakhari, Stephen Malnick, Helmut K. Seitz, Lawrence B Cohen, Mikko Salaspuro, Andreea Voinea-Griffin, Andrei Barasch, Irina A. Kirpich, Paul G. Thomes, Laura W. Schrum, Terrence M. Donohue, Kusum K. Kharbanda, Marcus Cruz, Mihai Opris. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damageExperimental and Molecular Pathology 2017; 102(1): 162 doi: 10.1016/j.yexmp.2017.01.003
76
Manuela França, João Mota Louro. Imaging of the Liver and Intra-hepatic Biliary TractMedical Radiology 2021; : 251 doi: 10.1007/978-3-030-38983-3_13
77
Nadia S. Orona, Francisco Astort, Guillermo A. Maglione, Sebastian A. Ferraro, Maximiliano Martin, Celina Morales, Patricia M. Mandalunis, Fernando Brites, Deborah R. Tasat. Hazardous effects of urban air particulate matter acute exposure on lung and extrapulmonary organs in miceEcotoxicology and Environmental Safety 2020; 190: 110120 doi: 10.1016/j.ecoenv.2019.110120
78
Mara Lúcia de Campos, Maria Fernanda Fernandes, Marina B. de Castro, Artur D. Campos, Paula P. Pires, Rafaela de O. Andrade, Isadora M. de Oliveira, Aristóbolo M. da Silva, Céphora Maria Sabarense, Maria Christina M.N. Castañon, Ana Eliza Andreazzi, Elita Scio. A pharmaceutical formulation containing Cecropia pachystachya alleviates metabolic alterations in a hypercaloric diet obesity model in Swiss miceBiocatalysis and Agricultural Biotechnology 2022; 43: 102376 doi: 10.1016/j.bcab.2022.102376
79
G. Invernizzi, S. Modina, D. Corbani, V. Bronzo, L.F. Pisani, J.M. Caputo, A. Agazzi, V. Dell’Orto, G. Savoini. Hepatic and subcutaneous adipose tissue variations in transition dairy goats fed saturated or unsaturated fat supplemented dietsSmall Ruminant Research 2016; 144: 211 doi: 10.1016/j.smallrumres.2016.09.009
80
Jake P. Mann, Rita De Vito, Antonella Mosca, Anna Alisi, Matthew J. Armstrong, Massimiliano Raponi, Ulrich Baumann, Valerio Nobili. Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver diseaseHepatology 2016; 63(3): 745 doi: 10.1002/hep.28374
81
Antonella Mosca, Silvio Veraldi, Andrea Dellostrologo, Mariateresa Sanseviero, Valerio Nobili. Pediatric Hepatology and Liver Transplantation2019; : 279 doi: 10.1007/978-3-319-96400-3_17
82
Yasuyuki Shigematsu, Kazuhito Tanaka, Gulanbar Amori, Hiroaki Kanda, Yu Takahashi, Yutaka Takazawa, Kengo Takeuchi, Kentaro Inamura. Potential involvement of oncostatin M in the immunosuppressive tumor immune microenvironment in hepatocellular carcinoma with vessels encapsulating tumor clustersHepatology Research 2024; 54(4): 368 doi: 10.1111/hepr.13988
83
Paola Fierabracci, Anna Tamberi, Ferruccio Santini. Minimally Invasive Bariatric and Metabolic Surgery2015; : 25 doi: 10.1007/978-3-319-15356-8_4
84
Seul Ki Han, Soon Koo Baik, Moon Young Kim. Non-alcoholic fatty liver disease: Definition and subtypesClinical and Molecular Hepatology 2023; 29(Suppl): S5 doi: 10.3350/cmh.2022.0424
85
Yasuyuki Shigematsu, Gulanbar Amori, Kazuhito Tanaka, Keiichiro Kitahama, Hiroaki Kanda, Yu Takahashi, Yutaka Takazawa, Kengo Takeuchi, Kentaro Inamura. MHC class I loss is associated with biliary/progenitor cell features and “cold” tumor-immune microenvironment in hepatocellular carcinomaVirchows Archiv 2023; 483(2): 177 doi: 10.1007/s00428-023-03568-9
86
Viviane Brandão Amorim, Daniella Braz Parente, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Amanda Almeida Miranda, Cláudia Cravo Moreira, Flávia Ferreira Fernandes, Carlos Frederico Ferreira Campos, Nathalie Carvalho Leite, Renata de Mello Perez, Rosana Souza Rodrigues. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?World Journal of Hepatology 2020; 12(9): 661-671 doi: 10.4254/wjh.v12.i9.661
87
Frances L Byrne, Kyle L Hoehn. Subclassification of fatty liver by its pathogenesis: cIEFing is believingThe Journal of Pathology 2016; 239(1): 3 doi: 10.1002/path.4702
88
Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim. Non-alcoholic fatty liver disease: the pathologist’s perspectiveClinical and Molecular Hepatology 2023; 29(Suppl): S302 doi: 10.3350/cmh.2022.0329
89
Yasuyo Urasaki, Ronald R Fiscus, Thuc T Le. Molecular classification of fatty liver by high‐throughput profiling of protein post‐translational modificationsThe Journal of Pathology 2016; 238(5): 641 doi: 10.1002/path.4685
90
Nicholas Szary, R. Rector, Grace Uptergrove, Suzanne Ridenhour, Shivendra Shukla, John Thyfault, Lauren Koch, Steven Britton, Jamal Ibdah. High Intrinsic Aerobic Capacity Protects against Ethanol-Induced Hepatic Injury and Metabolic Dysfunction: Study Using High Capacity Runner Rat ModelBiomolecules 2015; 5(4): 3295 doi: 10.3390/biom5043295
91
Caezaan Keshvani, Jonathan Kopel, Hemant Goyal. Obeticholic Acid—A Pharmacological and Clinical ReviewFuture Pharmacology 2023; 3(1): 238 doi: 10.3390/futurepharmacol3010017
92
Manuel Moya. Pediatric Overweight and Obesity2023; : 153 doi: 10.1007/978-3-031-26727-7_6
93
Toshio Maeda, Satomi Miki, Naoaki Morihara, Yoshiyuki Kagawa. Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7636
94
Trevor W Reichman, George Therapondos, Maria-Stella Serrano, John Seal, Rachel Evers-Meltzer, Humberto Bohorquez, Ari Cohen, Ian Carmody, Emily Ahmed, David Bruce, George E Loss. “Weighing the risk”: Obesity and outcomes following liver transplantationWorld Journal of Hepatology 2015; 7(11): 1484-1493 doi: 10.4254/wjh.v7.i11.1484
95
Ville T. Männistö, Marko Simonen, Jenni Hyysalo, Pasi Soininen, Antti J. Kangas, Dorota Kaminska, Ananda K. Matte, Sari Venesmaa, Pirjo Käkelä, Vesa Kärjä, Johanna Arola, Helena Gylling, Henna Cederberg, Johanna Kuusisto, Markku Laakso, Hannele Yki‐Järvinen, Mika Ala‐Korpela, Jussi Pihlajamäki. Ketone body production is differentially altered in steatosis and non‐alcoholic steatohepatitis in obese humansLiver International 2015; 35(7): 1853 doi: 10.1111/liv.12769
96
Y. Yilmaz. Review article: non‐alcoholic fatty liver disease and osteoporosis – clinical and molecular crosstalkAlimentary Pharmacology & Therapeutics 2012; 36(4): 345 doi: 10.1111/j.1365-2036.2012.05196.x
97
Yi Tan, Weiguo Lao, Linda Xiao, Zhenzhong Wang, Wei Xiao, Mohamed A. Kamal, J. Paul Seale, Xianqin Qu. Managing the Combination of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome with Chinese Herbal Extracts in High-Fat-Diet Fed RatsEvidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/306738
98
Masato Yoneda, Hideki Fujii, Yoshio Sumida, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Kento Imajo, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshikazu Yoshikawa, Takeshi Okanoue. Platelet count for predicting fibrosis in nonalcoholic fatty liver diseaseJournal of Gastroenterology 2011; 46(11): 1300 doi: 10.1007/s00535-011-0436-4
99
You-Jin Choi, Yeonsoo Kim, Seonghwan Hwang. Role of Neutrophils in the Development of Steatotic Liver DiseaseSeminars in Liver Disease 2024; 44(03): 300 doi: 10.1055/s-0044-1789207
100
Saumya Jayakumar, Stephen A. Harrison, Rohit Loomba. Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver DiseaseCurrent Hepatology Reports 2016; 15(2): 86 doi: 10.1007/s11901-016-0296-8
101
Marion Imbault, Alex Faccinetto, Bruno-Félix Osmanski, Antoine Tissier, Thomas Deffieux, Jean-Luc Gennisson, Valérie Vilgrain, Mickaël Tanter. Robust sound speed estimation for ultrasound-based hepatic steatosis assessmentPhysics in Medicine and Biology 2017; 62(9): 3582 doi: 10.1088/1361-6560/aa6226
102
Yoshihiro Kamada, Maaya Akita, Yuri Takeda, Shin Yamada, Hideki Fujii, Yoshiyuki Sawai, Yoshinori Doi, Hitomi Asazawa, Kotarosumitomo Nakayama, Kayo Mizutani, Hironobu Fujii, Takayuki Yakushijin, Masanori Miyazaki, Hisao Ezaki, Naoki Hiramatsu, Yuichi Yoshida, Shinichi Kiso, Yasuharu Imai, Norifumi Kawada, Tetsuo Takehara, Eiji Miyoshi, Silvia C. Sookoian. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic SteatohepatitisPLoS ONE 2013; 8(6): e66328 doi: 10.1371/journal.pone.0066328
103
Nishant Parmar, Muslim Atiq, Lee Austin, Ross A. Miller, Thomas Smyrk, Kabir Ahmed. Glycogenic Hepatopathy: Thinking Outside the BoxCase Reports in Gastroenterology 2015; 9(2): 221 doi: 10.1159/000437048
104
Taiyu Shang, Tianyi Jiang, Xiaowen Cui, Yufei Pan, Xiaofan Feng, Liwei Dong, Hongyang Wang. Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseasesGenes & Diseases 2024; 11(4): 100996 doi: 10.1016/j.gendis.2023.03.035
105
Geoffrey C. Farrell, Vincent Wai-Sun Wong, Shiv Chitturi. NAFLD in Asia—as common and important as in the WestNature Reviews Gastroenterology & Hepatology 2013; 10(5): 307 doi: 10.1038/nrgastro.2013.34
106
Carlotta Hoffmann, Philipp A. Gerber, Claudia Cavelti-Weder, Louisa Licht, Reham Kotb, Rania Al Dweik, Michele Cherfane, Stefan R. Bornstein, Nikolaos Perakakis. Liver, NAFLD and COVID-19Hormone and Metabolic Research 2022; 54(08): 522 doi: 10.1055/a-1834-9008
107
Claus Hellerbrand, Jörn M. Schattenberg, Philipp Peterburs, Anja Lechner, Reto Brignoli. The potential of silymarin for the treatment of hepatic disordersClinical Phytoscience 2017; 2(1) doi: 10.1186/s40816-016-0019-2
108
Yosuke Kawano, Masahiro Tanabe, Fumi Kameda, Mayumi Higashi, Kenichiro Ihara, Masaya Tanabe, Atsuo Inoue, Taiga Kobayashi, Takaaki Ueda, Katsuyoshi Ito. Lobar hepatic steatosis: Association with portal flow hemodynamics evaluated by multiphasic dynamic contrast-enhanced CTEuropean Journal of Radiology 2023; 160: 110688 doi: 10.1016/j.ejrad.2023.110688
109
Can Jiang, Yuriko Saiki, Shuto Hirota, Kosei Iwata, Xinyue Wang, Yutaka Ito, Keigo Murakami, Takehiro Imura, Jun Inoue, Atsushi Masamune, Akiyoshi Hirayama, Masafumi Goto, Toru Furukawa. Ablation of Dual-Specificity Phosphatase 6 Protects against Nonalcoholic Fatty Liver Disease via Cytochrome P450 4A and Mitogen-Activated Protein KinaseThe American Journal of Pathology 2023; 193(12): 1988 doi: 10.1016/j.ajpath.2023.09.003
110
Eva Morán‐Salvador, Marta López‐Parra, Verónica García‐Alonso, Esther Titos, Marcos Martínez‐Clemente, Ana González‐Périz, Cristina López‐Vicario, Yaacov Barak, Vicente Arroyo, Joan Clària. Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockoutsThe FASEB Journal 2011; 25(8): 2538 doi: 10.1096/fj.10-173716
111
Kameliya Bratoeva, Silviya Nikolova, Albena Merdzhanova, George St. Stoyanov, Eleonora Dimitrova, Javor Kashlov, Nikolay Conev, Mariya Radanova. Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic SyndromeMetabolic Syndrome and Related Disorders 2018; 16(7): 350 doi: 10.1089/met.2017.0162
112
Azam Asilian Bidgoli, Shahryar Rahnamayan, Taher Dehkharghanian, Ali Grami, H.R. Tizhoosh. Bias reduction in representation of histopathology images using deep feature selectionScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24317-z
113
Maria Luger, Renate Kruschitz, Christian Kienbacher, Stefan Traussnigg, Felix B. Langer, Karin Schindler, Tanja Würger, Friedrich Wrba, Michael Trauner, Gerhard Prager, Bernhard Ludvik. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D DeficiencyObesity Surgery 2016; 26(10): 2425 doi: 10.1007/s11695-016-2123-2
114
Gustavo Macedo HADDAD, Martinho Antonio GESTIC, Murillo Pimentel UTRINI, Felipe David Mendonça CHAIM, Elinton Adami CHAIM, Everton CAZZO. DIAGNOSTIC ACCURACY OF THE NON-INVASIVE MARKERS NFLS, NI-NASH-DS, AND FIB-4 FOR ASSESSMENT OF DIFFERENT ASPECTS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN INDIVIDUALS WITH OBESITY: CROSS-SECTIONAL STUDYArquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-050
115
Heloisa Aparecida Barbosa Silva Pereira, Aline Salgado Dionizio, Mileni Silva Fernandes, Tamara Teodoro Araujo, Tânia Mary Cestari, Camila Peres Buzalaf, Flávia Godoy Iano, Marília Afonso Rabelo Buzalaf, Michael Bader. Fluoride Intensifies Hypercaloric Diet-Induced ER Oxidative Stress and Alters Lipid MetabolismPLOS ONE 2016; 11(6): e0158121 doi: 10.1371/journal.pone.0158121
116
Sven M. Francque, W. J. Kwanten, D. van der Graaff. Portal Hypertension in NASH: Is It Different from Other Aetiologies?Current Hepatology Reports 2019; 18(2): 134 doi: 10.1007/s11901-019-00459-z
117
Gene P. Ables. Update on Ppar and Nonalcoholic Fatty Liver DiseasePPAR Research 2012; 2012: 1 doi: 10.1155/2012/912351
118
Suzan Schwertheim, Julia Kälsch, Holger Jastrow, Christoph Matthias Schaefer, Sarah Theurer, Saskia Ting, Ali Canbay, Heiner Wedemeyer, Kurt Werner Schmid, Hideo Andreas Baba. Characterization of two types of intranuclear hepatocellular inclusions in NAFLDScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71646-y
119
Laura Draijer, Marc Benninga, Bart Koot. Pediatric NAFLD: an overview and recent developments in diagnostics and treatmentExpert Review of Gastroenterology & Hepatology 2019; 13(5): 447 doi: 10.1080/17474124.2019.1595589
120
Paulina Głuszyńska, Dorota Lemancewicz, Janusz Bogdan Dzięcioł, Hady Razak Hady. Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A ReviewJournal of Clinical Medicine 2021; 10(24): 5721 doi: 10.3390/jcm10245721
121
Y. Yilmaz. Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?Alimentary Pharmacology & Therapeutics 2012; 36(9): 815 doi: 10.1111/apt.12046
122
Hidekatsu Kuroda, Tamami Abe, Yudai Fujiwara, Tomoaki Nagasawa, Yasuhiro Takikawa. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver diseaseJournal of Medical Ultrasonics 2021; 48(4): 471 doi: 10.1007/s10396-021-01123-0
123
Thing-Fong Tzeng, Shorong-Shii Liou, I.-Min Liu. 6-Gingerol mitigates nutritional steatohepatitis through regulating key genes related to oxidative stress, inflammation and fibrogenesisRSC Adv. 2014; 4(106): 61427 doi: 10.1039/C4RA12030B
124
Jesse D. Riordan, Joseph H. Nadeau. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouseMammalian Genome 2014; 25(9-10): 473 doi: 10.1007/s00335-014-9521-3
125
Adviti Naik, Rok Košir, Damjana Rozman. Genomic aspects of NAFLD pathogenesisGenomics 2013; 102(2): 84 doi: 10.1016/j.ygeno.2013.03.007
126
Hua Li, Wonbeak Yoo, Hye-Mi Park, Soo-Youn Lim, Dong-Ha Shin, Seokho Kim, Ho-Yong Park, Tae-Sook Jeong. Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse ModelInternational Journal of Molecular Sciences 2019; 20(9): 2325 doi: 10.3390/ijms20092325
127
Kutay Kirdok, Özge Yogurtcu, Tahir Buran, Elmas Kasap. Can the FIB-4 score predict the severity of acute pancreatitis in NAFLD?Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00313-y
128
Mohammad Alomari, Mamoon Ur Rashid, Pravallika Chadalavada, Jonathan Ragheb, Hammad Zafar, Zoilo Karim Suarez, Shrouq Khazaaleh, Adalberto Jose Gonzalez, Fernando J Castro. Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomesWorld Journal of Hepatology 2023; 15(4): 477-496 doi: 10.4254/wjh.v15.i4.477
129
Joanna Podgorska, Agnieszka Anysz-Grodzicka, Andrzej Cieszanowski. State-of-the-art MR Imaging of Fat-containing Focal Lesions of the LiverCurrent Medical Imaging Formerly Current Medical Imaging Reviews 2019; 15(5): 435 doi: 10.2174/1573405614666171218154838
130
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto de Andrade, Ana Lúcia dos Anjos Ferreira, Camila Renata Corrêa, Fernando Moreto. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese RatsAntioxidants 2019; 8(8): 276 doi: 10.3390/antiox8080276
131
Stephen D. H. Malnick, Pavel Alin, Marina Somin, Manuela G. Neuman. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but DifferentInternational Journal of Molecular Sciences 2022; 23(24): 16226 doi: 10.3390/ijms232416226
132
Maria Magdalena Quetglas-Llabrés, Margalida Monserrat-Mesquida, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Josep A. Tur, Antoni Sureda. Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized TrialAntioxidants 2024; 13(7): 754 doi: 10.3390/antiox13070754
133
Chelsea Hearn, Betty J. Ellington, Roberta Jones. The Role of the Nurse Practitioner in the Management of Nonalcoholic Fatty Liver DiseaseGastroenterology Nursing 2018; 41(5): 424 doi: 10.1097/SGA.0000000000000394
134
Kristina-Ana Klaric, Jacqueline Louise Parai, Charis Anthea Kepron, Alfredo Eugene Walker, Christopher Mark Milroy. Postmortem survey of haemoglobin A1c, non-alcoholic steatohepatitis and liver fibrosis within a general populationJournal of Clinical Pathology 2023; 76(9): 606 doi: 10.1136/jclinpath-2021-207998
135
Mawia Khairalseed, Katherine Brown, Kevin J. Parker, Kenneth Hoyt. Real-time H-scan ultrasound imaging using a Verasonics research scannerUltrasonics 2019; 94: 28 doi: 10.1016/j.ultras.2018.12.010
136
Alexandra Collin de l’Hortet, Kazuki Takeishi, Jorge Guzman-Lepe, Kazutoyo Morita, Abhinav Achreja, Branimir Popovic, Yang Wang, Kan Handa, Anjali Mittal, Noah Meurs, Ziwen Zhu, Frank Weinberg, Michael Salomon, Ira J. Fox, Chu-Xia Deng, Deepak Nagrath, Alejandro Soto-Gutierrez. Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 MetabolismCell Metabolism 2019; 30(2): 385 doi: 10.1016/j.cmet.2019.06.017
137
Nina Bastati, Diana Feier, Andreas Wibmer, Stefan Traussnigg, Csilla Balassy, Dietmar Tamandl, Henrik Einspieler, Friedrich Wrba, Michael Trauner, Christian Herold, Ahmed Ba-Ssalamah. Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid–enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept StudyRadiology 2014; 271(3): 739 doi: 10.1148/radiol.14131890
138
Yoshihisa Takahashi, Toshio Fukusato. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisWorld Journal of Gastroenterology 2014; 20(42): 15539-15548 doi: 10.3748/wjg.v20.i42.15539
139
Ivana Cerović, Dušan Mladenović, Rada Ješić, Tamara Naumović, Miloš Branković, Danijela Vučević, Vuk Aleksić, Tatjana Radosavljević. Alcoholic liver disease/nonalcoholic fatty liver disease indexEuropean Journal of Gastroenterology & Hepatology 2013; 25(8): 899 doi: 10.1097/MEG.0b013e32835f0786
140
Aline Dionizio, Heloisa Aparecida Barbosa Silva Pereira, Tamara Teodoro Araujo, Isabela Tomazini Sabino-Arias, Mileni Silva Fernandes, Karina Aparecida Oliveira, Fabielle Sales Raymundo, Tânia Mary Cestari, Fernando Neves Nogueira, Rui Albuquerque Carvalho, Marília Afonso Rabelo Buzalaf. Effect of Duration of Exposure to Fluoride and Type of Diet on Lipid Parameters and De Novo LipogenesisBiological Trace Element Research 2019; 190(1): 157 doi: 10.1007/s12011-018-1542-4
141
Dieter Furthner, Daniel Weghuber, Christopher Dalus, Andreas Lukas, Hannah N. Stundner-Ladenhauf, Harald Mangge, Thomas Pixner. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research GapsHormone Research in Paediatrics 2022; 95(2): 167 doi: 10.1159/000518595
142
Manorama Swain, Preetam Nath, Prasant Kumar Parida, Jimmy Narayan, Pradeep Kumar Padhi, Girish Kumar Pati, Ayaskanta Singh, Bijay Misra, Debasis Misra, Sanjib Kumar Kar, Manas Kumar Panigrahi, Chudamani Meher, Omprakash Agrawal, Niranjan Rout, Kaumudee Pattnaik, Pallavi Bhuyan, Pramila Kumari Mishra, Shivaram Prasad Singh. Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological CorrelationIndian Journal of Clinical Biochemistry 2017; 32(3): 306 doi: 10.1007/s12291-016-0612-7
143
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation2021; : 108 doi: 10.1016/B978-0-7020-7584-1.00007-3
144
Olga H. Orasan, Mihaela Iancu, Madalina Sava, Aniela Saplontai‐Pop, Angela Cozma, Simina Tarmure Sarlea, Corneliu Lungoci, Marius‐Ionut Ungureanu, Vasile Negrean, Dorel Sampelean, Dan Lucian Dumitrascu. Non‐invasive assessment of liver fibrosis in chronic viral hepatitisEuropean Journal of Clinical Investigation 2015; 45(12): 1243 doi: 10.1111/eci.12543
145
Garyfallia Kapravelou, Rosario Martínez, Ana M. Andrade, Elena Nebot, Daniel Camiletti-Moirón, Virginia A. Aparicio, Maria Lopez-Jurado, Pilar Aranda, Francisco Arrebola, Eduardo Fernandez-Segura, Giovanna Bermano, Marie Goua, Milagros Galisteo, Jesus M. Porres. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker ratsApplied Physiology, Nutrition, and Metabolism 2015; 40(12): 1242 doi: 10.1139/apnm-2015-0141
146
Bin Teng, Chen Huang, Chuan-Li Cheng, Anjaneyulu Udduttula, Xiang-Fang Yu, Chang Liu, Jian Li, Zhen-Yu Yao, Jing Long, Li-Fu Miao, Chao Zou, Jun Chu, Jian V. Zhang, Pei-Gen Ren. Newly identified peptide hormone inhibits intestinal fat absorption and improves NAFLD through its receptor GPRC6AJournal of Hepatology 2020; 73(2): 383 doi: 10.1016/j.jhep.2020.02.026
147
Daniella Braz Parente, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Lilian Machado-Silva, Fatima Aparecida Ferreira Figueiredo, Valeria Lanzoni, Carlos Frederico Ferreira Campos, Pedro Emmanuel Alvarenga Americano do Brasil, Marilia de Brito Gomes, Renata de Mello Perez, Rosana Souza Rodrigues, Erica Villa. Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic PatientsPLOS ONE 2015; 10(5): e0125653 doi: 10.1371/journal.pone.0125653
148
Amirhossein Sahebkar, Elena Sancho, David Abelló, Jordi Camps, Jorge Joven. Novel circulating biomarkers for non‐alcoholic fatty liver disease: A systematic reviewJournal of Cellular Physiology 2018; 233(2): 849 doi: 10.1002/jcp.25779
149
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
150
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation2016; : 101 doi: 10.1016/B978-0-7020-5548-5.00007-4
151
Stephanie Coulon, Sven Francque, Isabelle Colle, An Verrijken, Bram Blomme, Femke Heindryckx, Steffi De Munter, Janne Prawitt, Sandrine Caron, Bart Staels, Hans Van Vlierberghe, Luc Van Gaal, Anja Geerts. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver diseaseCytokine 2012; 59(2): 442 doi: 10.1016/j.cyto.2012.05.001
152
Tomasz Dziodzio, Matthias Biebl, Robert Öllinger, Johann Pratschke, Christian Denecke. The Role of Bariatric Surgery in Abdominal Organ Transplantation—the Next Big Challenge?Obesity Surgery 2017; 27(10): 2696 doi: 10.1007/s11695-017-2854-8
153
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt, Alastair D. Burt. MacSween's Pathology of the Liver2024; : 330 doi: 10.1016/B978-0-7020-8228-3.00005-3
154
Yusuf Yilmaz. Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?World Journal of Hepatology 2012; 4(12): 332-334 doi: 10.4254/wjh.v4.i12.332
155
Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Manuela Abbate, Sofía Montemayor, Catalina M. Mascaró, Miguel Casares, Silvia Tejada, Itziar Abete, Maria Angeles Zulet, Josep A. Tur, J. Alfredo Martínez, Antoni Sureda. Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver DiseaseAntioxidants 2020; 9(8): 759 doi: 10.3390/antiox9080759
156
Haoyu Tian, Shuairan Zhang, Ying Liu, Yifan Wu, Dianbao Zhang. Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and ChallengesInternational Journal of Molecular Sciences 2023; 24(5): 4583 doi: 10.3390/ijms24054583
157
Andrew J. Muir. Understanding the Complexities of CirrhosisClinical Therapeutics 2015; 37(8): 1822 doi: 10.1016/j.clinthera.2015.05.507
158
R. W. H. Hui, W.‐K. Seto, K.‐S. Cheung, L.‐Y. Mak, K. S. H. Liu, J. Fung, D. K.‐H. Wong, C.‐L. Lai, M.‐F. Yuen. Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case‐control studyJournal of Viral Hepatitis 2018; 25(1): 97 doi: 10.1111/jvh.12766
159
Munechika Enjoji, Kenichiro Yasutake, Motoyuki Kohjima, Makoto Nakamuta. Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of CholesterolInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/925807
160
Hideki Kumagai, Koji Yokoyama, Kimito Katsuyama, Shoji Hara, Hiroaki Yamamoto, Takanori Yamagata, Nobuyuki Taniguchi, Norio Hirota, Kouichi Itoh. A New Method for Measuring the Speed of Sound in Rat Liver ex Vivo Using an Ultrasound System: Correlation of Sound Speed with Fat DepositionUltrasound in Medicine & Biology 2014; 40(10): 2499 doi: 10.1016/j.ultrasmedbio.2014.03.019
161
Matthew C. Sinton, David C. Hay, Amanda J. Drake. Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenomeClinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0702-5
162
Renao Yan, Qiming He, Yiqing Liu, Peng Ye, Lianghui Zhu, Shanshan Shi, Jizhou Gou, Yonghong He, Tian Guan, Guangde Zhou. Unpaired virtual histological staining using prior-guided generative adversarial networksComputerized Medical Imaging and Graphics 2023; 105: 102185 doi: 10.1016/j.compmedimag.2023.102185
163
Claudia Della Corte, Anna Alisi, Alessia Saccari, Rita De Vito, Andrea Vania, Valerio Nobili. Nonalcoholic Fatty Liver in Children and Adolescents: An OverviewJournal of Adolescent Health 2012; 51(4): 305 doi: 10.1016/j.jadohealth.2012.01.010
164
Wei Zhong, Yantao Zhao, Xinguo Sun, Zhenyuan Song, Craig J. McClain, Zhanxiang Zhou, Marcia B. Aguila. Dietary Zinc Deficiency Exaggerates Ethanol-Induced Liver Injury in Mice: Involvement of Intrahepatic and Extrahepatic FactorsPLoS ONE 2013; 8(10): e76522 doi: 10.1371/journal.pone.0076522
165
Yueming Tang, Lijuan Zhang, Christopher B. Forsyth, Maliha Shaikh, Shiwen Song, Ali Keshavarzian. The Role of miR‐212 and iNOS in Alcohol‐Induced Intestinal Barrier Dysfunction and SteatohepatitisAlcoholism: Clinical and Experimental Research 2015; 39(9): 1632 doi: 10.1111/acer.12813
166
Michael Doulberis, Stergios A. Polyzos, Apostolis Papaefthymiou, Panagiotis Katsinelos, Christos Kiosses, Jannis Kountouras. Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescentsExpert Opinion on Pharmacotherapy 2020; 21(3): 247 doi: 10.1080/14656566.2019.1702967
167
D. van der Graaff, W.J. Kwanten, S.M. Francque. The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitisMedical Hypotheses 2019; 122: 188 doi: 10.1016/j.mehy.2018.11.014
168
Si-Yuan Pan, Qing Yu, Yi Zhang, Xiao-Yan Wang, Nan Sun, Zhi-Ling Yu, Kam-Ming Ko. Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicityLipids in Health and Disease 2012; 11(1) doi: 10.1186/1476-511X-11-120
169
Noa Mashav, Oren Shibolet. Liver Metabolism and Fatty Liver DiseaseOxidative Stress and Disease 2014; 20144564: 3 doi: 10.1201/b17315-3
170
Saechol Park, Jeongwoo Choi, Kyeonga Kim, Donghyun Oh, Junghee Yoon, Mincheol Choi. Point shear wave elastography of the liver in healthy adult catsAmerican Journal of Veterinary Research 2021; 82(4): 286 doi: 10.2460/ajvr.82.4.286
171
Carmelo García‐Monzón, Javier Vargas‐Castrillón, José Luís Porrero, María Teresa Alonso, Oscar Bonachía, María José Castillo, Alberto Marcos, Esther Quirós, Beatriz Ramos, Carlos Sánchez‐Cabezudo, Sol Villar, Alicia Sáez, Javier Rodríguez de Cía, Elvira del Pozo, Lorena Vega‐Piris, Susana Soto‐Fernández, Oreste Lo Iacono, María Eugenia Miquilena‐Colina. Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstonesLiver International 2015; 35(8): 1983 doi: 10.1111/liv.12813
172
Raj Vuppalanchi, Mohammad S. Siddiqui, Mark L. Van Natta, Erin Hallinan, Danielle Brandman, Kris Kowdley, Brent A. Neuschwander‐Tetri, Rohit Loomba, Srinivas Dasarathy, Manal Abdelmalek, Edward Doo, James A. Tonascia, David E. Kleiner, Arun J. Sanyal, Naga Chalasani. Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver diseaseHepatology 2018; 67(1): 134 doi: 10.1002/hep.29489
173
Michael J. J. Chu, Anthony R. J. Phillips, Alexander W. G. Hosking, Julia R. MacDonald, Adam S. J. R. Bartlett, Anthony J. R. Hickey, Carlos M. Rodriguez-Ortigosa. Hepatic Mitochondrial Function Analysis Using Needle Liver Biopsy SamplesPLoS ONE 2013; 8(10): e79097 doi: 10.1371/journal.pone.0079097
174
Mawia Khairalseed, Girdhari Rijal, Kenneth Hoyt. Spatial comparison between the H -scan format for classification of ultrasound scatterers and histology - Preliminary results using an animal model of breast cancer2020 IEEE International Ultrasonics Symposium (IUS) 2020; : 1 doi: 10.1109/IUS46767.2020.9251789
175
Helena S. Leitão, Cláudia Paulino, Dírcea Rodrigues, Sónia I. Gonçalves, Cristina Marques, Manuela Carvalheiro, Carlos F.G.C. Geraldes, Filipe Caseiro-Alves. MR Fat Fraction MappingAcademic Radiology 2013; 20(8): 957 doi: 10.1016/j.acra.2013.05.004
176
Carmelo García‐Monzón, Oreste Lo Iacono, Javier Crespo, Manuel Romero‐Gómez, Javier García‐Samaniego, Miguel Fernández‐Bermejo, Agustín Domínguez‐Díez, Javier Rodríguez de Cía, Alicia Sáez, José Luís Porrero, Javier Vargas‐Castrillón, Enrique Chávez‐Jiménez, Susana Soto‐Fernández, Ainhoa Díaz, Rocío Gallego‐Durán, Antonio Madejón, María Eugenia Miquilena‐Colina. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver diseaseEuropean Journal of Clinical Investigation 2014; 44(1): 65 doi: 10.1111/eci.12192
177
Caroline S. Stokes, Frank Lammert, Marcin Krawczyk. Short-term Dietary Interventions for the Management of Nonalcoholic Fatty LiverCurrent Medicinal Chemistry 2019; 26(19): 3483 doi: 10.2174/0929867324666170508144409
178
Monjur Ahmed. Non-alcoholic fatty liver disease in 2015World Journal of Hepatology 2015; 7(11): 1450-1459 doi: 10.4254/wjh.v7.i11.1450
179
Jason Ostenson, Bruce M. Damon, E. Brian Welch. MR fingerprinting with simultaneous T1, T2, and fat signal fraction estimation with integrated B0 correction reduces bias in water T1 and T2 estimatesMagnetic Resonance Imaging 2019; 60: 7 doi: 10.1016/j.mri.2019.03.017
180
Zoltan Pataky, Laurence Genton, Laurent Spahr, Vladimir Lazarevic, Sylvain Terraz, Nadia Gaïa, Laura Rubbia-Brandt, Alain Golay, Jacques Schrenzel, Claude Pichard. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot StudyDigestive Diseases and Sciences 2016; 61(9): 2721 doi: 10.1007/s10620-016-4179-1
181
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher, Amedeo Lonardo. Clinical relevance of liver histopathology and different histological classifications of NASH in adultsExpert Review of Gastroenterology & Hepatology 2018; 12(4): 351 doi: 10.1080/17474124.2018.1415756
182
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Obesity, Fatty Liver and Liver CancerAdvances in Experimental Medicine and Biology 2018; 1061: 139 doi: 10.1007/978-981-10-8684-7_11
183
Hunain Aslam, Fouzia Oza, Khalid Ahmed, Jonathan Kopel, Mark M. Aloysius, Aman Ali, Dushyant Singh Dahiya, Muhammad Aziz, Abhilash Perisetti, Hemant Goyal. The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature ReviewInternational Journal of Molecular Sciences 2023; 24(4): 3487 doi: 10.3390/ijms24043487
184
S. Berardis, E. Sokal. Pediatric non-alcoholic fatty liver disease: an increasing public health issueEuropean Journal of Pediatrics 2014; 173(2): 131 doi: 10.1007/s00431-013-2157-6
185
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker‐Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopyJournal of Biophotonics 2017; 10(12): 1703 doi: 10.1002/jbio.201600303
186
Hazem M. El-Ashmawy, Azza M. Ahmed. Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetesEuropean Journal of Gastroenterology & Hepatology 2019; 31(7): 859 doi: 10.1097/MEG.0000000000001354
187
Christoph Jüngst, Thomas Berg, Jun Cheng, Richard M. Green, Jidong Jia, Andrew L. Mason, Frank Lammert. Intrahepatic cholestasis in common chronic liver diseasesEuropean Journal of Clinical Investigation 2013; 43(10): 1069 doi: 10.1111/eci.12128
188
Jonas Roberto Velasco-Chong, Oscar Herrera-Calderón, Juan Pedro Rojas-Armas, Renán Dilton Hañari-Quispe, Linder Figueroa-Salvador, Gilmar Peña-Rojas, Vidalina Andía-Ayme, Ricardo Ángel Yuli-Posadas, Andres F. Yepes-Perez, Cristian Aguilar. TOCOSH FLOUR (Solanum tuberosum L.): A Toxicological Assessment of Traditional Peruvian Fermented PotatoesFoods 2020; 9(6): 719 doi: 10.3390/foods9060719
189
Willy Theel, Bianca M. Boxma‐de Klerk, Femme Dirksmeier‐Harinck, Elisabeth F. C. van Rossum, Danny A. Kanhai, Jan Apers, Bas M. van Dalen, Robert J. de Knegt, Adriaan G. Holleboom, Maarten E. Tushuizen, Diederick E. Grobbee, Janneke Wiebolt, Manuel Castro Cabezas. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniquesObesity Reviews 2022; 23(8) doi: 10.1111/obr.13481
190
Xu Li, Xiaolin Guo, Huifan Ji, Ge Yu, Pujun Gao. Gallstones in Patients with Chronic Liver DiseasesBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/9749802
191
Maria Apostolopoulou, Ruth Gordillo, Chrysi Koliaki, Sofia Gancheva, Tomas Jelenik, Elisabetta De Filippo, Christian Herder, Daniel Markgraf, Frank Jankowiak, Irene Esposito, Matthias Schlensak, Philipp E. Scherer, Michael Roden. Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic SteatohepatitisDiabetes Care 2018; 41(6): 1235 doi: 10.2337/dc17-1318
192
Oana Irina Gavril, Lidia Iuliana Arhire, Ovidiu Mitu, Radu Sebastian Gavril, Alexandra Mastaleru, Madalina Ioana Zota, Maria-Magdalena Leon-Constantin, Teodor Vasilcu, Laura Mihalache, Florin Mitu. Metabolic Syndrome and Nonalcoholic Fatty Liver DiseaseInternal Medicine 2019; 16(1): 51 doi: 10.2478/inmed-2019-0052
193
Hideki Kumagai, Kazuto Kobayashi, Sachiko Yoshida, Koji Yokoyama, Norio Hirota, Takanori Yamagata. Use of Ultrasound Microscopy for Ex Vivo Analysis of Acoustic Impedance in Mouse Liver with SteatohepatitisAcoustics 2020; 3(1): 3 doi: 10.3390/acoustics3010002
194
Brittany E. Wichman, Jamie Nilson, Srinivas Govindan, Alan Chen, Aditya Jain, Varsha Arun, Juana Derdoy, Joseph Krebs, Ajay K. Jain. Beyond lipids: Novel mechanisms for parenteral nutrition–associated liver diseaseNutrition in Clinical Practice 2022; 37(2): 265 doi: 10.1002/ncp.10830
195
Kun Young Kim, Ji Soo Song, Stephan Kannengiesser, Young Min Han. Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage areaLa radiologia medica 2015; 120(12): 1083 doi: 10.1007/s11547-015-0545-x
196
Stephanie Coulon, Vanessa Legry, Femke Heindryckx, Christophe Van Steenkiste, Christophe Casteleyn, Kim Olievier, Louis Libbrecht, Peter Carmeliet, Bart Jonckx, Jean-Marie Stassen, Hans Van Vlierberghe, Isabelle Leclercq, Isabelle Colle, Anja Geerts. Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent modelsHepatology 2013; 57(5): 1793 doi: 10.1002/hep.26219
197
K. Shubham, L. Vinay, P. K. Vinod. Systems-level organization of non-alcoholic fatty liver disease progression networkMolecular BioSystems 2017; 13(9): 1898 doi: 10.1039/C7MB00013H
198
Xinyu Zhang, Xuehua Gao, Pengpeng Zhang, Yanrong Guo, Haoming Lin, Xianfen Diao, Yingxia Liu, Changfeng Dong, Yaxin Hu, Siping Chen, Xin Chen. Dynamic mechanical analysis to assess viscoelasticity of liver tissue in a rat model of nonalcoholic fatty liver diseaseMedical Engineering & Physics 2017; 44: 79 doi: 10.1016/j.medengphy.2017.02.014
199
Victor de Lédinghen, Julien Vergniol, Juliette Foucher, Wassil Merrouche, Brigitte le Bail. Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastographyLiver International 2012; 32(6): 911 doi: 10.1111/j.1478-3231.2012.02820.x
200
Nutan Sharma, Lakhwinder Singh, Aditya Sharma, Ajay Kumar, Dinesh Mahajan. NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitorsPharmacological Research 2024; 208: 107375 doi: 10.1016/j.phrs.2024.107375
201
Xuan Shen, Wenxing Zheng, Xinna Du, Yuping Chen, Xianping song, Liucai Yang, Qi Yuan. The role of C5aR1-mediated hepatic macrophage efferocytosis in NASHScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68207-y
202
Genetics of nonalcoholic fatty liver disease in Asian populationsJournal of Genetics 2019; 98(1) doi: 10.1007/s12041-019-1071-8
203
Hyejeong Jwa, Youngshim Choi, Ui-Hyun Park, Soo-Jong Um, Seung Kew Yoon, Taesun Park. Piperine, an LXRα antagonist, protects against hepatic steatosis and improves insulin signaling in mice fed a high-fat dietBiochemical Pharmacology 2012; 84(11): 1501 doi: 10.1016/j.bcp.2012.09.009
204
Yoshihiro Kamada, Hideki Fujii, Hironobu Fujii, Yoshiyuki Sawai, Yoshinori Doi, Naofumi Uozumi, Kayo Mizutani, Maaya Akita, Motoya Sato, Sachiho Kida, Noriaki Kinoshita, Nobuhiro Maruyama, Takayuki Yakushijin, Masanori Miyazaki, Hisao Ezaki, Naoki Hiramatsu, Yuichi Yoshida, Shinichi Kiso, Yasuharu Imai, Norifumi Kawada, Tetsuo Takehara, Eiji Miyoshi. Serum Mac‐2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitisPROTEOMICS – Clinical Applications 2013; 7(9-10): 648 doi: 10.1002/prca.201200137
205
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Eugeniusz Tarasów, Małgorzata Wojtkowska, Irena Białokoz-Kalinowska, Dariusz Marek Lebensztejn. Predictive Role of Interleukin-18 in Liver Steatosis in Obese ChildrenCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3870454
206
Juliette Schönberg, Jürgen Borlak. miRNA biomarkers to predict risk of primary non-function of fatty allografts and drug induced acute liver failuresMolecular and Cellular Biochemistry 2024;  doi: 10.1007/s11010-024-05129-3
207
Rhiannon N. Hardwick, Daniel W. Ferreira, Vijay R. More, April D. Lake, Zhenqiang Lu, Jose E. Manautou, Angela L. Slitt, Nathan J. Cherrington. Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver DiseaseDrug Metabolism and Disposition 2013; 41(3): 554 doi: 10.1124/dmd.112.048439
208
Ludovico Abenavoli, Michel Beaugrand. Transient elastography in non-alcoholic fatty liver diseaseAnnals of Hepatology 2012; 11(2): 172 doi: 10.1016/S1665-2681(19)31021-X
209
Chong Teik Tan, Natalie Jun Hui Soh, Hao‐Chun Chang, Victor C. Yu. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identitiesThe FEBS Journal 2023; 290(4): 892 doi: 10.1111/febs.16317
210
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advancesThe Journal of Pathology 2017; 241(1): 36 doi: 10.1002/path.4829
211
Peter Greaves. Histopathology of Preclinical Toxicity Studies2012; : 433 doi: 10.1016/B978-0-444-53856-7.00009-9
212
Dario F. De Jesus, Kazuki Orime, Dorota Kaminska, Tomohiko Kimura, Giorgio Basile, Chih-Hao Wang, Larissa Haertle, Renzo Riemens, Natalie K. Brown, Jiang Hu, Ville Männistö, Amélia M. Silva, Ercument Dirice, Yu-Hua Tseng, Thomas Haaf, Jussi Pihlajamäki, Rohit N. Kulkarni. Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in miceJournal of Clinical Investigation 2020; 130(5): 2391 doi: 10.1172/JCI127502
213
Margarita Papatheodoridi, Jean Baptiste Hiriart, Monica Lupsor-Platon, Fabrizio Bronte, Jerome Boursier, Omar Elshaarawy, Fabio Marra, Maja Thiele, Georgios Markakis, Audrey Payance, Edgar Brodkin, Laurent Castera, George Papatheodoridis, Aleksander Krag, Umberto Arena, Sebastian Mueller, Paul Cales, Vincenza Calvaruso, Victor de Ledinghen, Massimo Pinzani, Emmanuel A. Tsochatzis. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver diseaseJournal of Hepatology 2021; 74(5): 1109 doi: 10.1016/j.jhep.2020.11.050
214
Margarita Papatheodoridi, Victor De Ledinghen, Monica Lupsor-Platon, Fabrizio Bronte, Jerome Boursier, Omar Elshaarawy, Fabio Marra, Maja Thiele, Georgios Markakis, Audrey Payance, Edgar Brodkin, Laurent Castera, George Papatheodoridis, Aleksander Krag, Umberto Arena, Sebastian Mueller, Paul Cales, Vincenza Calvaruso, Adele Delamarre, Massimo Pinzani, Emmanuel A. Tsochatzis. Agile scores in MASLD and ALD: External validation and their utility in clinical algorithmsJournal of Hepatology 2024; 81(4): 590 doi: 10.1016/j.jhep.2024.05.021
215
Yoshihiro Kamada, Eiji Miyoshi. Mac-2 Binding Protein is a Useful Liver Fibrosis Biomarker for NAFLD/NASHTrends in Glycoscience and Glycotechnology 2017; 29(170): E85 doi: 10.4052/tigg.1714.1E
216
Benjamin Rivière, Audrey Jaussent, Valérie Macioce, Stéphanie Faure, Nicolas Builles, Patrick Lefebvre, Philippe Géraud, Marie-Christine Picot, Sandra Rebuffat, Eric Renard, Valérie Paradis, Marie-Dominique Servais, Nathalie de Preville, David Nocca, Anne-Dominique Lajoix, Georges-Philippe Pageaux, Florence Galtier. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patientsDiabetes & Metabolism 2022; 48(4): 101345 doi: 10.1016/j.diabet.2022.101345
217
Daniella Braz Parente, Rosana Souza Rodrigues, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Lilian Machado-Silva, Valeria Lanzoni, Carlos Frederico Ferreira Campos, Antonio Luis Eiras-Araujo, Pedro Emmanuel Alvarenga Americano do Brasil, Philippe Garteiser, Marilia de Brito Gomes, Renata de Mello Perez, Ferruccio Bonino. Is MR Spectroscopy Really the Best MR-Based Method for the Evaluation of Fatty Liver in Diabetic Patients in Clinical Practice?PLoS ONE 2014; 9(11): e112574 doi: 10.1371/journal.pone.0112574
218
Claudia Della Corte, Antonella Mosca, Andrea Vania, Arianna Alterio, Salvatore Iasevoli, Valerio Nobili. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian StudyNutrition 2017; : 8 doi: 10.1016/j.nut.2017.02.008
219
Paulo Reis-Júnior, Ryan Tanigawa, Gustavo Heluani Antunes de Mesquita, Natalia Basan, Venâncio Alves, Luiz Augusto Carneiro D'Albuquerque, Wellington Andraus. Steatosis and steatohepatitis found in adults after death due to non-burn traumaClinics 2019; 74: e1070 doi: 10.6061/clinics/2019/e1070
220
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver DisorderCurrent Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
221
Michael J.J. Chu, Ryash Vather, Anthony J.R. Hickey, Anthony R.J. Phillips, Adam S.J.R. Bartlett. Impact of ischaemic preconditioning on experimental steatotic livers following hepatic ischaemia–reperfusion injury: a systematic reviewHPB 2015; 17(1): 1 doi: 10.1111/hpb.12258
222
Erica Jennison, Christopher D. Byrne. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver diseaseClinical and Molecular Hepatology 2021; 27(1): 22 doi: 10.3350/cmh.2020.0129
223
Jonna Weisell, Anna-Kaisa Ruotsalainen, Juha Näpänkangas, Matti Jauhiainen, Jaana Rysä. Menaquinone 4 increases plasma lipid levels in hypercholesterolemic miceScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82724-0
224
Mercedes Vazquez-Chantada, Aintzane Gonzalez-Lahera, Ibon Martinez-Arranz, Carmelo Garcia-Monzon, Manuela M. Regueiro, Juan L. Garcia-Rodriguez, Karin A. Schlangen, Iñaki Mendibil, Naiara Rodriguez-Ezpeleta, Juan J. Lozano, Karina Banasik, Johanne M. Justesen, Torben Joergensen, Daniel R. Witte, Torsten Lauritzen, Torben Hansen, Oluf Pedersen, Nicolas Veyrie, Karine Clement, Joan Tordjman, Albert Tran, Yannik Le Marchand-Brustel, Xabier Buque, Patricia Aspichueta, Jose J. Echevarria-Uraga, Antonio Martin-Duce, Joan Caballeria, Philippe Gual, Azucena Castro, Jose M. Mato, Maria L. Martinez-Chantar, Ana M. Aransay. Solute Carrier Family 2 Member 1 Is Involved in the Development of Nonalcoholic Fatty Liver DiseaseHepatology 2013; 57(2): 505 doi: 10.1002/hep.26052
225
Marlies Bekaert, D. Margriet Ouwens, Tina Hörbelt, Frederique Van de Velde, Pia Fahlbusch, Daniella Herzfeld de Wiza, Yves Van Nieuwenhove, Patrick Calders, Marleen Praet, Anne Hoorens, Anja Geerts, Xavier Verhelst, Jean‐Marc Kaufman, Bruno Lapauw. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesityObesity 2016; 24(12): 2544 doi: 10.1002/oby.21674
226
Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuo Yu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker Kellogg, Peter So, Hanry Yu, Jie Yan, J. Quincy Brown, Ton G. van Leeuwen. A classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopyClinical and Preclinical Optical Diagnostics 2017; : 101 doi: 10.1117/12.2281445
227
Andrew J. Krentz, Pierre Bedossa. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 245 doi: 10.1007/978-3-030-11748-1_10
228
Christoph Grander, Felix Grabherr, Herbert Tilg. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment optionsCardiovascular Research 2023; 119(9): 1787 doi: 10.1093/cvr/cvad095
229
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz. Hígado graso (parte 2): enfoque clínico y tratamientoRevista colombiana de Gastroenterología 2023; 38(1): 46 doi: 10.22516/25007440.979
230
Azza S. M. Awad, Ekram N. Abd Al Haleem, Wesam M. El-Bakly, Mohie A. Sherief. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosisNaunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4): 381 doi: 10.1007/s00210-015-1207-1
231
Hideki Kumagai, Nobuyuki Taniguchi, Koji Yokoyama, Kimito Katsuyama, Hiroaki Yamamoto, Shoji Hara, Norio Hirota, Kouichi Itoh, Takanori Yamagata. The Speed of Sound in Rat Liver With Steatohepatitis: Ex Vivo Analysis Using Two Types of Ultrasound SystemsUltrasound in Medicine & Biology 2019; 45(8): 2258 doi: 10.1016/j.ultrasmedbio.2019.05.004
232
Thierry Lefebvre, Léonie Petitclerc, Mélanie Hébert, Laurent Bilodeau, Giada Sebastiani, Damien Olivié, Zu‐Hua Gao, Marie‐Pierre Sylvestre, Guy Cloutier, Bich N. Nguyen, Guillaume Gilbert, An Tang. MRI cine‐tagging of cardiac‐induced motion for noninvasive staging of liver fibrosisJournal of Magnetic Resonance Imaging 2020; 51(5): 1570 doi: 10.1002/jmri.26935
233
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisComputational and Structural Biotechnology Journal 2023; 21: 2495 doi: 10.1016/j.csbj.2023.03.048
234
Ellen Callewaert, Jochem Louisse, Nynke Kramer, Julen Sanz-Serrano, Mathieu Vinken. Computational ToxicologyMethods in Molecular Biology 2025; 2834: 249 doi: 10.1007/978-1-0716-4003-6_12
235
Bita V. Naini, Samuel W. French. Practical Atlas of Transplant Pathology2016; : 111 doi: 10.1007/978-3-319-23054-2_5
236
Yi Jiang, Salil Chowdhury, Bing-Hong Xu, Mohamad Aghaie Meybodi, Konstantinos Damiris, Samanthika Devalaraju, Nikolaos Pyrsopoulos. Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for <i>Clostridioides difficile</i> infectionWorld Journal of Hepatology 2021; 13(11): 1777-1790 doi: 10.4254/wjh.v13.i11.1777
237
Jihane N. Benhammou, Arthur Ko, Marcus Alvarez, Minna U. Kaikkonen, Carl Rankin, Kristina M. Garske, David Padua, Yash Bhagat, Dorota Kaminska, Vesa Kärjä, Jussi Pihlajamäki, Joseph R. Pisegna, Päivi Pajukanta. Novel Lipid Long Intervening Noncoding RNA, Oligodendrocyte Maturation‐Associated Long Intergenic Noncoding RNA, Regulates the Liver Steatosis Gene Stearoyl‐Coenzyme A Desaturase As an Enhancer RNAHepatology Communications 2019; 3(10): 1356 doi: 10.1002/hep4.1413
238
Cyrielle Caussy, Meera Soni, Jeffrey Cui, Ricki Bettencourt, Nicholas Schork, Chi-Hua Chen, Mahdi Al Ikhwan, Shirin Bassirian, Sandra Cepin, Monica P. Gonzalez, Michel Mendler, Yuko Kono, Irine Vodkin, Kristin Mekeel, Jeffrey Haldorson, Alan Hemming, Barbara Andrews, Joanie Salotti, Lisa Richards, David A. Brenner, Claude B. Sirlin, Rohit Loomba. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosisJournal of Clinical Investigation 2017; 127(7): 2697 doi: 10.1172/JCI93465
239
Mario Masarone, Valerio Rosato, Andrea Aglitti, Tommaso Bucci, Rosa Caruso, Teresa Salvatore, Ferdinando Carlo Sasso, Marie Francoise Tripodi, Marcello Persico, Patricia Aspichueta. Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damagePLOS ONE 2017; 12(6): e0178473 doi: 10.1371/journal.pone.0178473
240
Sara Karjoo. Is There an Association of Vascular Disease and Atherosclerosis in Children and Adolescents With Obesity and Non-alcoholic Fatty Liver Disease?Frontiers in Pediatrics 2018; 6 doi: 10.3389/fped.2018.00345
241
Laura Giuseppina Di Pasqua, Marta Cagna, Clarissa Berardo, Mariapia Vairetti, Andrea Ferrigno. Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An UpdateBiomedicines 2022; 10(1): 194 doi: 10.3390/biomedicines10010194
242
Sandy Feng, Jennifer C. Lai. Expanded Criteria DonorsClinics in Liver Disease 2014; 18(3): 633 doi: 10.1016/j.cld.2014.05.005
243
Antonio Orlacchio, Francesca Bolacchi, Marco Antonicoli, Irene Coco, Elisa Costanzo, Daniela Tosti, Simona Francioso, Mario Angelico, Giovanni Simonetti. Liver Elasticity in NASH Patients Evaluated with Real-Time Elastography (RTE)Ultrasound in Medicine & Biology 2012; 38(4): 537 doi: 10.1016/j.ultrasmedbio.2011.12.023
244
Shailendra Arindkar, Jashdeep Bhattacharjee, Jerald Mahesh Kumar, Barun Das, Pramod Upadhyay, Shajahan Asif, Ramesh C Juyal, Subeer S Majumdar, Nagarajan Perumal. Antigen peptide transporter 1 is involved in the development of fructose‐induced hepatic steatosis in miceJournal of Gastroenterology and Hepatology 2013; 28(8): 1403 doi: 10.1111/jgh.12186
245
Mônica Rodrigues de Araújo Souza, Margareth de Fátima Formiga de Melo Diniz, José Eymard Moraes de Medeiros-Filho, Maria Salete Trigueiro de Araújo. Metabolic syndrome and risk factors for non-alcoholic fatty liver diseaseArquivos de Gastroenterologia 2012; 49(1): 89 doi: 10.1590/S0004-28032012000100015
246
Victoria Sid, Yaw L. Siow, Karmin O. Role of folate in nonalcoholic fatty liver diseaseCanadian Journal of Physiology and Pharmacology 2017; 95(10): 1141 doi: 10.1139/cjpp-2016-0681
247
Milena Vesković, Milica Labudović-Borović, Ivan Zaletel, Jelena Rakočević, Dušan Mladenović, Bojan Jorgačević, Danijela Vučević, Tatjana Radosavljević. The Effects of Betaine on the Nuclear Fractal Dimension, Chromatin Texture, and Proliferative Activity in Hepatocytes in Mouse Model of Nonalcoholic Fatty Liver DiseaseMicroscopy and Microanalysis 2018; 24(2): 132 doi: 10.1017/S1431927617012806
248
Lin Ding, Jun-Lin Liu, Waseem Hassan, Lu-Lu Wang, Fang-Rong Yan, Jing Shang. Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytesScientific Reports 2014; 4(1) doi: 10.1038/srep04715
249
Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Kento Imajo, Yoshio Sumida, Yuichiro Eguchi, Hideki Fujii, Hideyuki Hyogo, Masafumi Ono, Yasuaki Suzuki, Takumi Kawaguchi, Kazuaki Chayama, Saiyu Tanaka, Kazuma Fujimoto, Keizo Anzai, Toshiji Saibara, Michio Sata, Yoshito Itoh, Atsushi Nakajima, Takeshi Okanoue; Japan Study Group of NAFLD (JSG-NAFLD). Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(29): 10108-10114 doi: 10.3748/wjg.v20.i29.10108
250
Shelly Kakar, Mohannad Dugum, Ricardo Cabello, Abhinav Humar, Jawad Ahmad, Shahid M. Malik. Incidence of Recurrent NASH-Related Allograft CirrhosisDigestive Diseases and Sciences 2019; 64(5): 1356 doi: 10.1007/s10620-018-5413-9
251
Neeta B. Amin, Santos Carvajal-Gonzalez, Julie Purkal, Tong Zhu, Collin Crowley, Sylvie Perez, Kristin Chidsey, Albert M. Kim, Bryan Goodwin. Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitisScience Translational Medicine 2019; 11(520) doi: 10.1126/scitranslmed.aav9701
252
Chung Eun Lee. Effects of Intermittent Fasting on Splenic Galectin-3 Protein Expression in High-fat Diet-fed MiceAnatomy & Biological Anthropology 2023; 36(4): 209 doi: 10.11637/aba.2023.36.4.209
253
Masato Yoneda, Kento Imajo, Yuichiro Eguchi, Hideki Fujii, Yoshio Sumida, Hideyuki Hyogo, Masafumi Ono, Yasuaki Suzuki, Takumi Kawaguchi, Noriaki Aoki, Michio Sata, Kazuyuki Kanemasa, Yutaka Kohgo, Toshiji Saibara, Kazuaki Chayama, Yoshito Itoh, Toshikazu Yoshikawa, Keizo Anzai, Kazuma Fujimoto, Takeshi Okanoue, Atsushi Nakajima. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levelsJournal of Gastroenterology 2013; 48(9): 1051 doi: 10.1007/s00535-012-0704-y
254
Eiji Miyoshi, Yoshihiro Kamada. Application of glycoscience to the early detection of pancreatic cancerCancer Science 2016; 107(10): 1357 doi: 10.1111/cas.13011
255
Angela C Cheung, Brian D Juran, Erik M Schlicht, Bryan M McCauley, Elizabeth J Atkinson, Raymond Moore, Julie K Heimbach, Kymberly D Watt, Tsung-Teh Wu, Nicholas F LaRusso, Gregory J Gores, Zhifu Sun, Konstantinos N Lazaridis. DNA Methylation Profile of Liver Tissue in End-Stage Cholestatic Liver DiseaseEpigenomics 2022; 14(8): 481 doi: 10.2217/epi-2021-0343
256
Michael J. J. Chu, Anthony J. R. Hickey, Anthony R. J. Phillips, Adam S. J. R. Bartlett. The Impact of Hepatic Steatosis on Hepatic Ischemia-Reperfusion Injury in Experimental Studies: A Systematic ReviewBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/192029
257
Hilmar K L&uuml;ckhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesWorld Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
258
Junling Wang, Ping Li, Zhilong Jiang, Qiuhui Yang, Yuqiang Mi, Yonggang Liu, Ruifang Shi, Yonghe Zhou, Jinsheng Wang, Wei Lu, Si Li, Dan Liu. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLDThe Korean Journal of Internal Medicine 2016; 31(3): 479 doi: 10.3904/kjim.2015.253
259
Gaspard d'Assignies, Cindy Fayard, Helena Leitao, Toni Alfaiate, Florence Tubach, Safi Dokmak, Valérie Paradis, Bernard E. Van Beers, Maxime Ronot, Valérie Vilgrain. Liver steatosis assessed by preoperative MRI: An independent risk factor for severe complications after major hepatic resectionSurgery 2016; 159(4): 1050 doi: 10.1016/j.surg.2015.10.008
260
Daniella Braz Parente, Hugo Perazzo, Fernando Fernandes Paiva, Carlos Frederico Ferreira Campos, Carlos José Saboya, Silvia Elaine Pereira, Felipe d’Almeida e Silva, Rosana Souza Rodrigues, Renata de Mello Perez. Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71723-2
261
Raj Vuppalanchi, Marshall E. McCabe, Sweta R. Tandra, Siva P. Parcha, Adil Ghafoor, Leslie Schuh, Margaret M. Inman, Don J. Selzer, Dimitrios Stefanidis, Naga Chalasani. Safety and Efficacy of Bariatric Surgery in Cirrhosis Patients With Extreme ObesityAnnals of Surgery 2022; 275(1): e174 doi: 10.1097/SLA.0000000000003891
262
Ayako Suzuki, Anna Mae Diehl. Nonalcoholic SteatohepatitisAnnual Review of Medicine 2017; 68(1): 85 doi: 10.1146/annurev-med-051215-031109
263
Olivier Govaere, Quentin M. Anstee. Encyclopedia of Cell Biology2023; : 610 doi: 10.1016/B978-0-12-821618-7.00265-0
264
B. Claire McDyre, Mohamed Diwan M. AbdulHameed, Matthew G. Permenter, William E. Dennis, Christine E. Baer, Jason M. Koontz, Molly H. Boyle, Anders Wallqvist, John A. Lewis, Danielle L. Ippolito. Comparative Proteomic Analysis of Liver Steatosis and Fibrosis after Oral Hepatotoxicant Administration in Sprague-Dawley RatsToxicologic Pathology 2018; 46(2): 202 doi: 10.1177/0192623317747549
265
Anita Lal, Jacqueline L. Parai, Christopher M. Milroy. Liver Pathology in First Presentation Diabetic Ketoacidosis at AutopsyAcademic Forensic Pathology 2016; 6(2): 271 doi: 10.23907/2016.028
266
Keith C. Summa, Robin M. Voigt, Christopher B. Forsyth, Maliha Shaikh, Kate Cavanaugh, Yueming Tang, Martha Hotz Vitaterna, Shiwen Song, Fred W. Turek, Ali Keshavarzian, David L. Boone. Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and InflammationPLoS ONE 2013; 8(6): e67102 doi: 10.1371/journal.pone.0067102
267
Silvia Gaia, Daniela Campion, Andrea Evangelista, Maurizio Spandre, Loretta Cosso, Franco Brunello, Giovannino Ciccone, Elisabetta Bugianesi, Mario Rizzetto. Non‐invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound dataLiver International 2015; 35(8): 2027 doi: 10.1111/liv.12761
268
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in miceBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
269
C. Venturi, C. Sempoux, J. Bueno, J.C. Ferreres Pinas, C. Bourdeaux, J. Abarca-Quinones, J. Rahier, R. Reding. Novel Histologic Scoring System for Long-Term Allograft Fibrosis After Liver Transplantation in ChildrenAmerican Journal of Transplantation 2012; 12(11): 2986 doi: 10.1111/j.1600-6143.2012.04210.x
270
Consolato M. Sergi, Mohit Kehar, Carolina Jimenez-Rivera. Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocolTherapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241227766
271
Dipali Sharma, Neeraj K. Saxena. Murine Models, Energy Balance, and CancerEnergy Balance and Cancer 2015; 10: 247 doi: 10.1007/978-3-319-16733-6_12
272
Valerio Nobili, Anna Alisi, Kimberly P. Newton, Jeffrey B. Schwimmer. Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver DiseaseGastroenterology 2016; 150(8): 1798 doi: 10.1053/j.gastro.2016.03.009
273
Zita Galvin, Ramraj Rajakumar, Emily Chen, Oyedele Adeyi, Markus Selzner, David Grant, Gonzalo Sapisochin, Paul Greig, Mark Cattral, Ian McGilvray, Anand Ghanekar, Nazia Selzner, Les Lilly, Keyur Patel, Mamatha Bhat. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated FibrosisLiver Transplantation 2019; 25(1): 56 doi: 10.1002/lt.25338
274
Sa’ed H. Zyoud, Samer O. Alalalmeh, Omar E. Hegazi, Muna Shakhshir, Faris Abushamma, Samah W. Al-Jabi. An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysisGut Pathogens 2024; 16(1) doi: 10.1186/s13099-024-00624-w
275
Karima Begriche, Julie Massart, Marie-Anne Robin, Fabrice Bonnet, Bernard Fromenty. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver diseaseHepatology 2013; 58(4): 1497 doi: 10.1002/hep.26226
276
Fatih Eren, Ramazan Kurt, Fatih Ermis, Ozlen Atug, Nese Imeryuz, Yusuf Yilmaz. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver diseaseClinical Biochemistry 2012; 45(9): 655 doi: 10.1016/j.clinbiochem.2012.03.019
277
Devy Maulidya Cahyani, Andang Miatmoko, Berlian Sarasitha Hariawan, Kusuma Eko Purwantari, Retno Sari. N-nitrosodiethylamine induces inflammation of liver in miceJournal of Basic and Clinical Physiology and Pharmacology 2021; 32(4): 505 doi: 10.1515/jbcpp-2020-0475
278
Hanxiang Zhong. Non-alcoholic fatty liver disease: pathogenesis and modelsAmerican Journal of Translational Research 2024; 16(2): 387 doi: 10.62347/KMSA5983
279
Kyung Eun Kim, Hyun Joo Shin, Yeajin Ju, Youngae Jung, Hyeong Seok An, So Jeong Lee, Eun Ae Jeong, Jaewoong Lee, Geum-Sook Hwang, Gu Seob Roh. Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome PathwayNutrients 2023; 15(21): 4574 doi: 10.3390/nu15214574
280
Robin C. Su, Apurva Lad, Joshua D. Breidenbach, Thomas M. Blomquist, William T. Gunning, Prabhatchandra Dube, Andrew L. Kleinhenz, Deepak Malhotra, Steven T. Haller, David J. Kennedy, Luca Vanella. Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD)PLOS ONE 2019; 14(12): e0225604 doi: 10.1371/journal.pone.0225604
281
Neeta B. Amin, Aditi R. Saxena, Veena Somayaji, Robert Dullea. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of PharmacologyClinical Therapeutics 2023; 45(1): 55 doi: 10.1016/j.clinthera.2022.12.008
282
Mustapha Najimi, Sébastien Michel, Maria M. Binda, Kris Gellynck, Nathalie Belmonte, Giuseppe Mazza, Noelia Gordillo, Yelena Vainilovich, Etienne Sokal. Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal ModelCells 2022; 11(18): 2854 doi: 10.3390/cells11182854
283
Noam Peleg, Assaf Issachar, Orly Sneh-Arbib, Amir Shlomai. AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver diseaseDigestive and Liver Disease 2017; 49(10): 1133 doi: 10.1016/j.dld.2017.05.002
284
Mona A. Elhosary, Mohammed Bahey-El-Din, Amany AbdelBary, Nadia El Guink, Hamida M. Aboushleib. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection modelMicrobial Pathogenesis 2019; 131: 181 doi: 10.1016/j.micpath.2019.04.014
285
Stephanie Breher-Esch, Nishika Sahini, Anna Trincone, Christin Wallstab, Jürgen Borlak. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver diseaseBMC Medical Genomics 2018; 11(1) doi: 10.1186/s12920-018-0438-7
286
Mariana Perez-Robles, Wendy Campos-Perez, Juan José Rivera-Valdés, Ramón Antonio Franco-Topete, Eduardo Miguel Navarrete-Medina, Monserrat Maldonado-González, Bertha Ruíz-Madrigal, Sarai Citlalic Rodríguez-Reyes, Erika Martinez-Lopez. Elevated Serum Low-Density Lipoproteins-Cholesterol Levels and B1B2/B2B2 CETP Genotype Are Positively Associated with Nonalcoholic Fatty Liver Disease in Women with Gallstone DiseaseMetabolic Syndrome and Related Disorders 2023; 21(1): 41 doi: 10.1089/met.2022.0010
287
Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, Hideki Fujii, Yoshio Sumida, Kojiroh Mori, Saiyu Tanaka, Makoto Yamada, Maaya Akita, Kayo Mizutani, Hironobu Fujii, Akiko Yamamoto, Shinji Takamatsu, Yuichi Yoshida, Yoshito Itoh, Norifumi Kawada, Kazuaki Chayama, Toshiji Saibara, Tetsuo Takehara, Eiji Miyoshi. A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkersHepatology 2015; 62(5): 1433 doi: 10.1002/hep.28002
288
Yong-Jik Lee, Yoo-Na Jang, Yoon-Mi Han, Hyun-Min Kim, Jong-Min Jeong, Min Jeoung Son, Chang Bae Jin, Hyoung Ja Kim, Hong Seog Seo. Caffeoylquinic Acid-Rich Extract ofAster glehniF. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδand Adiponectin in ApoE KO MicePPAR Research 2017; 2017: 1 doi: 10.1155/2017/3912567
289
Jihane N. Benhammou, Elizabeth S. Aby, Gayaneh Shirvanian, Kohlett Manansala, Shehnaz K. Hussain, Myron J. Tong. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinomaScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66507-7
290
Anurak Bunnoy, Kanokporn Saenphet, Saisamorn Lumyong, Supap Saenphet, Siriwadee Chomdej. Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic ratsBMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0624-5
291
Kristina Önnerhag, Peter M. Nilsson, Stefan Lindgren. Insulin resistance with impaired fasting glucose increases the risk of NAFLDOpen Journal of Gastroenterology 2013; 3(03): 170 doi: 10.4236/ojgas.2013.33028
292
M Giannetti, P Piaggi, G Ceccarini, S Mazzeo, G Querci, P Fierabracci, G Salvetti, G Galli, I Ricco, S Martinelli, C Di Salvo, M Anselmino, A Landi, P Vitti, A Pinchera, F Santini. Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric bandingInternational Journal of Obesity 2012; 36(3): 336 doi: 10.1038/ijo.2011.243
293
Nadia F. Hassan, Gehan M. Soliman, Ebtsam F. Okasha, Amany M. Shalaby. Histological, Immunohistochemical and Biochemical Study of Experimentally Induced Fatty Liver in Adult Male Albino Rat and the Possible Protective Role of PomegranateJournal of Microscopy and Ultrastructure 2017;  doi: 10.1016/j.jmau.2017.04.001
294
Maria Lilibeth Manzanilla Valdez, Maira Rubi Segura Campos. Renal and Hepatic Disease:Cnidoscolus aconitifoliusas Diet Therapy Proposal for Prevention and TreatmentJournal of the American College of Nutrition 2021; 40(7): 646 doi: 10.1080/07315724.2020.1810171
295
Maddi Oses, María Medrano, Arkaitz Galbete, Lide Arenaza, Jonatan R. Ruiz, Felix Sánchez‐Valverde, Francisco B. Ortega, Idoia Labayen. A sociodemographic, anthropometric and lifestyle‐based prediction score for screening children with overweight and obesity for hepatic steatosis: The HEPAKID indexPediatric Obesity 2021; 16(8) doi: 10.1111/ijpo.12770
296
Yasuyuki Shigematsu, Hiroaki Kanda, Gulanbar Amori, Yu Takahashi, Yutaka Takazawa, Kentaro Inamura. Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liverMedicine 2022; 101(5): e28746 doi: 10.1097/MD.0000000000028746
297
Oskar Knittelfelder, Sofia Traikov, Olga Vvedenskaya, Andrea Schuhmann, Sandra Segeletz, Anna Shevchenko, Andrej Shevchenko. Shotgun Lipidomics Combined with Laser Capture Microdissection: A Tool To Analyze Histological Zones in Cryosections of TissuesAnalytical Chemistry 2018; 90(16): 9868 doi: 10.1021/acs.analchem.8b02004
298
Seonghwan Hwang, Hwayoung Yun, Sungwon Moon, Ye Eun Cho, Bin Gao. Role of Neutrophils in the Pathogenesis of Nonalcoholic SteatohepatitisFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.751802